ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
0.00%
US Tech 100
17,735.20
0.30%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36776
-0.01%
Bitcoin
62,674.40
2.00%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) News

ARDX

Ardelyx (ARDX)

Ardelyx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DateTimeSourceHeadlineSymbolCompany
05/09/20243:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/07/20243:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
05/07/20247:01AMGlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week ConferenceNASDAQ:ARDXArdelyx Inc
05/02/20243:02PMGlobeNewswire Inc.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
05/01/20247:00AMGlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical MeetingsNASDAQ:ARDXArdelyx Inc
04/18/20247:00AMGlobeNewswire Inc.Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:ARDXArdelyx Inc
03/28/20243:05PMGlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
03/25/20247:00AMGlobeNewswire Inc.Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and StrategyNASDAQ:ARDXArdelyx Inc
03/12/20243:35PMGlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
03/05/20243:21PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
02/28/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/27/20247:00AMGlobeNewswire Inc.Ardelyx to Participate at the Cowen 44th Annual Health Care ConferenceNASDAQ:ARDXArdelyx Inc
02/22/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20244:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20243:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20243:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/22/20243:40PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARDXArdelyx Inc
02/22/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
02/22/20243:01PMGlobeNewswire Inc.Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
02/22/20245:05AMIH Market NewsU.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond PositivelyNASDAQ:ARDXArdelyx Inc
02/13/20241:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
02/09/20243:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
02/08/20243:32PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
02/01/20247:00AMGlobeNewswire Inc.Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:ARDXArdelyx Inc
01/18/20243:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
01/18/20243:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
01/18/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
01/18/20243:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Your Recent History

BOV
JBFO11
Jbfo Fof Fundo DE Invest...
COIN
HBDEUR
Hive-Backed Dollar
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved